Edition:
United Kingdom

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

3.34USD
16 Jan 2019
Change (% chg)

$-0.01 (-0.45%)
Prev Close
$3.36
Open
$3.40
Day's High
$3.63
Day's Low
$3.32
Volume
55,221
Avg. Vol
44,969
52-wk High
$9.00
52-wk Low
$2.21

Chart for

About

Miragen Therapeutics, Inc., formerly Signal Genetics, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its clinical product... (more)

Overall

Beta: 1.97
Market Cap(Mil.): $202.81
Shares Outstanding(Mil.): 21.48
Dividend: --
Yield (%): --

Financials

  MGEN.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -11.08 -- --
ROI: -87.08 8.99 14.96
ROE: -90.87 10.13 16.53

Earnings vs. Estimates